L3VLUP
ProSign in

BLCO · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

BLCOJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • BLCO
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterBLCOJNJ
Q3 2020none listed holders, n.a.30 holders, $26.2bn
Q4 2020none listed holders, n.a.32 holders, $26.6bn
Q1 2021none listed holders, n.a.31 holders, $25.3bn
Q2 2021none listed holders, n.a.37 holders, $25.6bn
Q3 2021none listed holders, n.a.40 holders, $24.1bn
Q4 2021none listed holders, n.a.33 holders, $25.2bn
Q1 2022none listed holders, n.a.35 holders, $28.2bn
Q2 20223 holders, $63m33 holders, $26.9bn
Q3 20224 holders, $100m36 holders, $25.4bn
Q4 20222 holders, $63m35 holders, $27.6bn
Q1 20232 holders, $90m42 holders, $24.5bn
Q2 20233 holders, $87m38 holders, $25.0bn
Q3 20234 holders, $69m37 holders, $18.9bn
Q4 20234 holders, $66m31 holders, $19.0bn
Q1 20244 holders, $73m32 holders, $19.7bn
Q2 20245 holders, $74m35 holders, $20.4bn
Q3 20245 holders, $97m28 holders, $22.3bn
Q4 20245 holders, $82m37 holders, $20.4bn
Q1 20253 holders, $59m32 holders, $20.5bn
Q2 20254 holders, $101m31 holders, $18.4bn
Q3 20257 holders, $158m32 holders, $23.7bn
Q4 20257 holders, $198m29 holders, $27.8bn
Q1 20265 holders, $178m34 holders, $35.6bn
Q2 20266 holders, $203m33 holders, $39.1bn
BLCO

Bausch Lomb Corp

Holders
5
Reported value
$74m
Buyers
2
Sellers
1

Breadth +1 among 94 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
JNJ

Johnson & Johnson

Holders
35
Reported value
$20.4bn
Buyers
24
Sellers
8

Breadth +16 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2024

Among the 39 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only BLCO (4)

Carl C. Icahn, ExodusPoint Capital Management LP, PDT Partners LLC, Rokos Capital Management LLP

Only JNJ (34)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Caxton Associates LLP, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), GAMCO Investors Inc, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Quantbot Technologies LP, and 9 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →